Haleon PLC (LSE:HLN) — Market Cap & Net Worth
Market Cap & Net Worth: Haleon PLC (HLN)
Haleon PLC (LSE:HLN) has a market capitalization of $399.41 Million (GBX3.28 Trillion) as of July 31, 2026. Listed on the LSE stock exchange, this UK-based company holds position #13162 globally and #60 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Haleon PLC's stock price GBX368.60 by its total outstanding shares 8905873233 (8.91 Billion). See capital reinvestment ratio of Haleon PLC to understand how much of operating cash flow is reinvested back into capital assets.
Haleon PLC Market Cap History: 2022 to 2026
Haleon PLC's market capitalization history from 2022 to 2026. Data shows growth from $343.80 Million to $399.41 Million (3.57% CAGR).
Index Memberships
Haleon PLC is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE All-Share
FTAS
|
$72.54 Billion | 0.55% | #31 of 573 |
|
FTSE 350
FTLC
|
$72.14 Billion | 0.55% | #32 of 350 |
|
FTSE 100 Index (UK)
FTSE
|
$56.41 Billion | 0.71% | #25 of 100 |
Weight: Haleon PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Haleon PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Haleon PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Haleon PLC's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.28x
Haleon PLC's market cap is 0.28 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $343.80 Million | $10.86 Billion | $1.06 Billion | 0.03x | 0.32x |
| 2023 | $342.27 Million | $11.30 Billion | $1.05 Billion | 0.03x | 0.33x |
| 2024 | $408.95 Million | $11.23 Billion | $1.44 Billion | 0.04x | 0.28x |
Competitor Companies of HLN by Market Capitalization
Companies near Haleon PLC in the global market cap rankings as of July 31, 2026.
Key companies related to Haleon PLC by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #516 globally with a market cap of $51.01 Billion USD ( CN¥348.61 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #543 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #614 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #516 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $51.01 Billion | CN¥54.65 |
| #543 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $45.10 |
| #614 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €15.50 |
Haleon PLC Historical Marketcap From 2022 to 2026
Between 2022 and today, Haleon PLC's market cap moved from $343.80 Million to $ 399.41 Million, with a yearly change of 3.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX399.41 Million | -1.65% |
| 2025 | GBX406.13 Million | -0.69% |
| 2024 | GBX408.95 Million | +19.48% |
| 2023 | GBX342.27 Million | -0.45% |
| 2022 | GBX343.80 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 31st, 2026 the market cap of Haleon PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $399.41 Million USD |
| MoneyControl | $399.41 Million USD |
| MarketWatch | $399.41 Million USD |
| marketcap.company | $399.41 Million USD |
| Reuters | $399.41 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Haleon PLC
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene… Read more